About the Authors
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Department of Pathology, Division of Applied Molecular Oncology, University Health Network - Princess Margaret Hospital and Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada
Department of Surgery, Vancouver General Hospital, Vancouver, British Columbia
Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia
Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas
The authors have declared that no competing interests exist.
ICMJE criteria for authorship read and met: WWL RC BPC KLT CG CAM JC ACW DH CQZ TPB JY JCE CM MST AFG JDM SL WLL. Agree with the manuscript's results and conclusions: WWL RC BPC KLT CG CAM JC ACW DH CQZ TPB JY JCE CM MST AFG JDM SL WLL. Designed the experiments/the study: WWL KLT DH TPB WLL. Analyzed the data: WWL RC BPC KLT JC CQZ AFG WLL. Collected data/did experiments for the study: WWL KLT CG CAM JC ACW DH CQZ TPB JY JCE. Enrolled patients: JY SL. Wrote the first draft of the paper: WWL. Contributed to the writing of the paper: WWL RC BPC KLT JC ACW JY JCE CM AFG JDM SL WLL. Contributed tumor samples, review data, study results, and manuscript drafts/final version: MST. Contributed unique reagents and cell lines for the study, helped design the experiments, and analyzed the data: AFG. Provided lung cancer cell lines and immortalized normal human bronchial epithelial cell lines for key functional tests: JDM.